Access

Opinion

Nature 402, 703 (16 December 1999) | doi:10.1038/45310

naturejobs

More science jobs
Post a job for free

Gene therapy for the public

Top

The NIH has an opportunity to make its commitment to openness more purposeful.

The hearings held by the US National Institutes of Health (NIH) last week into problems that have arisen in adenovirus-based gene-therapy trials revealed clear breaches of protocol by some of the field's leading researchers, and inadequacies in the state of experimentation (see page 707). Adenoviruses are one of several types of vectors being tried in clinical gene-therapy studies.